Table of Content

1 Report Overview
1.1 Polypeptide Drug Definition
1.2 Market by Type
1.2.1 Global Polypeptide Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Injection
1.2.3 Nasal Administration
1.2.4 Lung Administration
1.2.5 Oral Administration
1.2.6 Transdermal Administration
1.3 Market Segment by Application
1.3.1 Global Polypeptide Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Immunity Regulating Medicine (Allergy Infection and Immune)
1.3.3 Digestive System Drugs (Gastrointestinal Type)
1.3.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
1.3.5 Gynecologic or Obstetric Drug
1.3.6 Tumor Drug
1.3.7 Urinary System Drug
1.3.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Polypeptide Drug Sales
2.1 Global Polypeptide Drug Revenue Estimates and Forecasts 2018-2034
2.2 Global Polypeptide Drug Revenue by Region: 2018 VS 2024 VS 2034
2.3 Global Polypeptide Drug Revenue by Region
2.3.1 Global Polypeptide Drug Revenue by Region (2018-2023)
2.3.2 Global Polypeptide Drug Revenue by Region (2024-2034)
2.4 Global Polypeptide Drug Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Polypeptide Drug Sales Quantity by Region: 2018 VS 2024 VS 2034
2.6 Global Polypeptide Drug Sales Quantity by Region
2.6.1 Global Polypeptide Drug Sales Quantity by Region (2018-2023)
2.6.2 Global Polypeptide Drug Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Polypeptide Drug Sales Quantity by Manufacturers
3.1.1 Global Polypeptide Drug Sales Quantity by Manufacturers (2018-2023)
3.1.2 Global Polypeptide Drug Sales Quantity Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Companies by Polypeptide Drug Sales in 2024
3.2 Global Polypeptide Drug Revenue by Manufacturers
3.2.1 Global Polypeptide Drug Revenue by Manufacturers (2018-2023)
3.2.2 Global Polypeptide Drug Revenue Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Polypeptide Drug Revenue in 2024
3.3 Global Polypeptide Drug Sales Price by Manufacturers
3.4 Global Key Players of Polypeptide Drug, Industry Ranking, 2021 VS 2024
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Polypeptide Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Polypeptide Drug, Product Offered and Application
3.8 Global Key Manufacturers of Polypeptide Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Polypeptide Drug Sales Quantity by Type
4.1.1 Global Polypeptide Drug Historical Sales Quantity by Type (2018-2023)
4.1.2 Global Polypeptide Drug Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Polypeptide Drug Sales Quantity Market Share by Type (2018-2034)
4.2 Global Polypeptide Drug Revenue by Type
4.2.1 Global Polypeptide Drug Historical Revenue by Type (2018-2023)
4.2.2 Global Polypeptide Drug Forecasted Revenue by Type (2024-2034)
4.2.3 Global Polypeptide Drug Revenue Market Share by Type (2018-2034)
4.3 Global Polypeptide Drug Price by Type
4.3.1 Global Polypeptide Drug Price by Type (2018-2023)
4.3.2 Global Polypeptide Drug Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Polypeptide Drug Sales Quantity by Application
5.1.1 Global Polypeptide Drug Historical Sales Quantity by Application (2018-2023)
5.1.2 Global Polypeptide Drug Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Polypeptide Drug Sales Quantity Market Share by Application (2018-2034)
5.2 Global Polypeptide Drug Revenue by Application
5.2.1 Global Polypeptide Drug Historical Revenue by Application (2018-2023)
5.2.2 Global Polypeptide Drug Forecasted Revenue by Application (2024-2034)
5.2.3 Global Polypeptide Drug Revenue Market Share by Application (2018-2034)
5.3 Global Polypeptide Drug Price by Application
5.3.1 Global Polypeptide Drug Price by Application (2018-2023)
5.3.2 Global Polypeptide Drug Price Forecast by Application (2024-2034)
6 North America
6.1 North America Polypeptide Drug Sales by Company
6.1.1 North America Polypeptide Drug Revenue by Company (2018-2023)
6.1.2 North America Polypeptide Drug Sales Quantity by Company (2018-2023)
6.2 North America Polypeptide Drug Market Size by Type
6.2.1 North America Polypeptide Drug Sales Quantity by Type (2018-2034)
6.2.2 North America Polypeptide Drug Revenue by Type (2018-2034)
6.3 North America Polypeptide Drug Market Size by Application
6.3.1 North America Polypeptide Drug Sales Quantity by Application (2018-2034)
6.3.2 North America Polypeptide Drug Revenue by Application (2018-2034)
6.4 North America Polypeptide Drug Market Size by Country
6.4.1 North America Polypeptide Drug Revenue by Country: 2018 VS 2024 VS 2034
6.4.2 North America Polypeptide Drug Revenue by Country (2018-2034)
6.4.3 North America Polypeptide Drug Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Polypeptide Drug Sales by Company
7.1.1 Europe Polypeptide Drug Sales Quantity by Company (2018-2023)
7.1.2 Europe Polypeptide Drug Revenue by Company (2018-2023)
7.2 Europe Polypeptide Drug Market Size by Type
7.2.1 Europe Polypeptide Drug Sales Quantity by Type (2018-2034)
7.2.2 Europe Polypeptide Drug Revenue by Type (2018-2034)
7.3 Europe Polypeptide Drug Market Size by Application
7.3.1 Europe Polypeptide Drug Sales Quantity by Application (2018-2034)
7.3.2 Europe Polypeptide Drug Revenue by Application (2018-2034)
7.4 Europe Polypeptide Drug Market Size by Country
7.4.1 Europe Polypeptide Drug Revenue by Country: 2018 VS 2024 VS 2034
7.4.2 Europe Polypeptide Drug Revenue by Country (2018-2034)
7.4.3 Europe Polypeptide Drug Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Polypeptide Drug Sales by Company
8.1.1 China Polypeptide Drug Sales Quantity by Company (2018-2023)
8.1.2 China Polypeptide Drug Revenue by Company (2018-2023)
8.2 China Polypeptide Drug Market Size by Type
8.2.1 China Polypeptide Drug Sales Quantity by Type (2018-2034)
8.2.2 China Polypeptide Drug Revenue by Type (2018-2034)
8.3 China Polypeptide Drug Market Size by Application
8.3.1 China Polypeptide Drug Sales Quantity by Application (2018-2034)
8.3.2 China Polypeptide Drug Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Polypeptide Drug Sales by Company
9.1.1 APAC Polypeptide Drug Sales Quantity by Company (2018-2023)
9.1.2 APAC Polypeptide Drug Revenue by Company (2018-2023)
9.2 APAC Polypeptide Drug Market Size by Type
9.2.1 APAC Polypeptide Drug Sales Quantity by Type (2018-2034)
9.2.2 APAC Polypeptide Drug Revenue by Type (2018-2034)
9.3 APAC Polypeptide Drug Market Size by Application
9.3.1 APAC Polypeptide Drug Sales Quantity by Application (2018-2034)
9.3.2 APAC Polypeptide Drug Revenue by Application (2018-2034)
9.4 APAC Polypeptide Drug Market Size by Region
9.4.1 APAC Polypeptide Drug Revenue by Region: 2018 VS 2024 VS 2034
9.4.2 APAC Polypeptide Drug Revenue by Region (2018-2034)
9.4.3 APAC Polypeptide Drug Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Polypeptide Drug Sales by Company
10.1.1 Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Company (2018-2023)
10.1.2 Middle East, Africa and Latin America Polypeptide Drug Revenue by Company (2018-2023)
10.2 Middle East, Africa and Latin America Polypeptide Drug Market Size by Type
10.2.1 Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Polypeptide Drug Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Polypeptide Drug Market Size by Application
10.3.1 Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Polypeptide Drug Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Polypeptide Drug Market Size by Country
10.4.1 Middle East, Africa and Latin America Polypeptide Drug Revenue by Country: 2018 VS 2024 VS 2034
10.4.2 Middle East, Africa and Latin America Polypeptide Drug Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.1.4 Novartis Polypeptide Drug Products and Services
11.1.5 Novartis Polypeptide Drug SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Merck Serono
11.2.1 Merck Serono Company Information
11.2.2 Merck Serono Overview
11.2.3 Merck Serono Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.2.4 Merck Serono Polypeptide Drug Products and Services
11.2.5 Merck Serono Polypeptide Drug SWOT Analysis
11.2.6 Merck Serono Recent Developments
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Information
11.3.2 Ferring Pharmaceuticals Overview
11.3.3 Ferring Pharmaceuticals Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.3.4 Ferring Pharmaceuticals Polypeptide Drug Products and Services
11.3.5 Ferring Pharmaceuticals Polypeptide Drug SWOT Analysis
11.3.6 Ferring Pharmaceuticals Recent Developments
11.4 Ipsen PHarma Biotech
11.4.1 Ipsen PHarma Biotech Company Information
11.4.2 Ipsen PHarma Biotech Overview
11.4.3 Ipsen PHarma Biotech Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.4.4 Ipsen PHarma Biotech Polypeptide Drug Products and Services
11.4.5 Ipsen PHarma Biotech Polypeptide Drug SWOT Analysis
11.4.6 Ipsen PHarma Biotech Recent Developments
11.5 Lilly
11.5.1 Lilly Company Information
11.5.2 Lilly Overview
11.5.3 Lilly Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.5.4 Lilly Polypeptide Drug Products and Services
11.5.5 Lilly Polypeptide Drug SWOT Analysis
11.5.6 Lilly Recent Developments
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Information
11.6.2 Asahi Kasei Overview
11.6.3 Asahi Kasei Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.6.4 Asahi Kasei Polypeptide Drug Products and Services
11.6.5 Asahi Kasei Polypeptide Drug SWOT Analysis
11.6.6 Asahi Kasei Recent Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Overview
11.7.3 AstraZeneca Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.7.4 AstraZeneca Polypeptide Drug Products and Services
11.7.5 AstraZeneca Polypeptide Drug SWOT Analysis
11.7.6 AstraZeneca Recent Developments
11.8 SciClone Pharmaceuticals
11.8.1 SciClone Pharmaceuticals Company Information
11.8.2 SciClone Pharmaceuticals Overview
11.8.3 SciClone Pharmaceuticals Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.8.4 SciClone Pharmaceuticals Polypeptide Drug Products and Services
11.8.5 SciClone Pharmaceuticals Polypeptide Drug SWOT Analysis
11.8.6 SciClone Pharmaceuticals Recent Developments
11.9 Takeda
11.9.1 Takeda Company Information
11.9.2 Takeda Overview
11.9.3 Takeda Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.9.4 Takeda Polypeptide Drug Products and Services
11.9.5 Takeda Polypeptide Drug SWOT Analysis
11.9.6 Takeda Recent Developments
11.10 Roche
11.10.1 Roche Company Information
11.10.2 Roche Overview
11.10.3 Roche Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.10.4 Roche Polypeptide Drug Products and Services
11.10.5 Roche Polypeptide Drug SWOT Analysis
11.10.6 Roche Recent Developments
11.11 Sanofi
11.11.1 Sanofi Company Information
11.11.2 Sanofi Overview
11.11.3 Sanofi Polypeptide Drug Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2023)
11.11.4 Sanofi Polypeptide Drug Products and Services
11.11.5 Sanofi Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Polypeptide Drug Value Chain Analysis
12.2 Polypeptide Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Polypeptide Drug Production Mode & Process
12.4 Polypeptide Drug Sales and Marketing
12.4.1 Polypeptide Drug Sales Channels
12.4.2 Polypeptide Drug Distributors
12.5 Polypeptide Drug Customers
13 Market Dynamics
13.1 Polypeptide Drug Industry Trends
13.2 Polypeptide Drug Market Drivers
13.3 Polypeptide Drug Market Challenges
13.4 Polypeptide Drug Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Polypeptide Drug Market Size Growth Rate (CAGR) by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Nasal Administration
Table 4. Major Manufacturers of Lung Administration
Table 5. Major Manufacturers of Oral Administration
Table 6. Major Manufacturers of Transdermal Administration
Table 7. Global Polypeptide Drug Market Size Growth Rate (CAGR) by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Polypeptide Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. Global Polypeptide Drug Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Polypeptide Drug Revenue Market Share by Region (2018-2023)
Table 11. Global Polypeptide Drug Revenue by Region (2024-2034) & (US$ Million)
Table 12. Global Polypeptide Drug Revenue Market Share by Region (2024-2034)
Table 13. Global Polypeptide Drug Sales Quantity by Region: 2018 VS 2024 VS 2034 (MT)
Table 14. Global Polypeptide Drug Sales by Region (2018-2023) & (MT)
Table 15. Global Polypeptide Drug Sales Market Share by Region (2018-2023)
Table 16. Global Polypeptide Drug Sales by Region (2024-2034) & (MT)
Table 17. Global Polypeptide Drug Sales Market Share by Region (2024-2034)
Table 18. Global Polypeptide Drug Sales Quantity by Manufacturers (2018-2023) & (MT)
Table 19. Global Polypeptide Drug Sales Quantity Share by Manufacturers (2018-2023)
Table 20. Global Polypeptide Drug Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Polypeptide Drug Revenue Share by Manufacturers (2018-2023)
Table 22. Global Polypeptide Drug Price by Manufacturers 2018-2023 (USD/MT)
Table 23. Global Key Players of Polypeptide Drug, Industry Ranking, 2021 VS 2024
Table 24. Global Polypeptide Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Polypeptide Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polypeptide Drug as of 2024)
Table 26. Global Key Manufacturers of Polypeptide Drug, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Polypeptide Drug, Product Offered and Application
Table 28. Global Key Manufacturers of Polypeptide Drug, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Polypeptide Drug Sales Quantity by Type (2018-2023) & (MT)
Table 31. Global Polypeptide Drug Sales Quantity by Type (2024-2034) & (MT)
Table 32. Global Polypeptide Drug Sales Quantity Share by Type (2018-2023)
Table 33. Global Polypeptide Drug Sales Quantity Share by Type (2024-2034)
Table 34. Global Polypeptide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Polypeptide Drug Revenue by Type (2024-2034) & (US$ Million)
Table 36. Global Polypeptide Drug Revenue Share by Type (2018-2023)
Table 37. Global Polypeptide Drug Revenue Share by Type (2024-2034)
Table 38. Polypeptide Drug Price by Type (2018-2023) & (USD/MT)
Table 39. Global Polypeptide Drug Price Forecast by Type (2024-2034) & (USD/MT)
Table 40. Global Polypeptide Drug Sales Quantity by Application (2018-2023) & (MT)
Table 41. Global Polypeptide Drug Sales Quantity by Application (2024-2034) & (MT)
Table 42. Global Polypeptide Drug Sales Quantity Share by Application (2018-2023)
Table 43. Global Polypeptide Drug Sales Quantity Share by Application (2024-2034)
Table 44. Global Polypeptide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Polypeptide Drug Revenue by Application (2024-2034) & (US$ Million)
Table 46. Global Polypeptide Drug Revenue Share by Application (2018-2023)
Table 47. Global Polypeptide Drug Revenue Share by Application (2024-2034)
Table 48. Polypeptide Drug Price by Application (2018-2023) & (USD/MT)
Table 49. Global Polypeptide Drug Price Forecast by Application (2024-2034) & (USD/MT)
Table 50. North America Polypeptide Drug Revenue by Company (2018-2023) & (US$ Million)
Table 51. North America Polypeptide Drug Sales Quantity by Company (2018-2023) & (MT)
Table 52. North America Polypeptide Drug Sales Quantity by Type (2018-2023) & (MT)
Table 53. North America Polypeptide Drug Sales Quantity by Type (2024-2034) & (MT)
Table 54. North America Polypeptide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 55. North America Polypeptide Drug Revenue by Type (2024-2034) & (US$ Million)
Table 56. North America Polypeptide Drug Sales Quantity by Application (2018-2023) & (MT)
Table 57. North America Polypeptide Drug Sales Quantity by Application (2024-2034) & (MT)
Table 58. North America Polypeptide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 59. North America Polypeptide Drug Revenue by Application (2024-2034) & (US$ Million)
Table 60. North America Polypeptide Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 61. North America Polypeptide Drug Revenue by Country (2018-2023) & (US$ Million)
Table 62. North America Polypeptide Drug Revenue by Country (2024-2034) & (US$ Million)
Table 63. North America Polypeptide Drug Sales Quantity by Country (2018-2023) & (MT)
Table 64. North America Polypeptide Drug Sales Quantity by Country (2024-2034) & (MT)
Table 65. Europe Polypeptide Drug Sales Quantity by Company (2018-2023) & (MT)
Table 66. Europe Polypeptide Drug Revenue by Company (2018-2023) & (US$ Million)
Table 67. Europe Polypeptide Drug Sales Quantity by Type (2018-2023) & (MT)
Table 68. Europe Polypeptide Drug Sales Quantity by Type (2024-2034) & (MT)
Table 69. Europe Polypeptide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Polypeptide Drug Revenue by Type (2024-2034) & (US$ Million)
Table 71. Europe Polypeptide Drug Sales Quantity by Application (2018-2023) & (MT)
Table 72. Europe Polypeptide Drug Sales Quantity by Application (2024-2034) & (MT)
Table 73. Europe Polypeptide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Polypeptide Drug Revenue by Application (2024-2034) & (US$ Million)
Table 75. Europe Polypeptide Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 76. Europe Polypeptide Drug Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Polypeptide Drug Revenue by Country (2024-2034) & (US$ Million)
Table 78. Europe Polypeptide Drug Sales Quantity by Country (2018-2023) & (MT)
Table 79. Europe Polypeptide Drug Sales Quantity by Country (2024-2034) & (MT)
Table 80. China Polypeptide Drug Sales Quantity by Company (2018-2023) & (MT)
Table 81. China Polypeptide Drug Revenue by Company (2018-2023) & (US$ Million)
Table 82. China Polypeptide Drug Sales Quantity by Type (2018-2023) & (MT)
Table 83. China Polypeptide Drug Sales Quantity by Type (2024-2034) & (MT)
Table 84. China Polypeptide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 85. China Polypeptide Drug Revenue by Type (2024-2034) & (US$ Million)
Table 86. China Polypeptide Drug Sales Quantity by Application (2018-2023) & (MT)
Table 87. China Polypeptide Drug Sales Quantity by Application (2024-2034) & (MT)
Table 88. China Polypeptide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 89. China Polypeptide Drug Revenue by Application (2024-2034) & (US$ Million)
Table 90. APAC Polypeptide Drug Sales Quantity by Company (2018-2023) & (MT)
Table 91. APAC Polypeptide Drug Revenue by Company (2018-2023) & (US$ Million)
Table 92. APAC Polypeptide Drug Sales Quantity by Type (2018-2023) & (MT)
Table 93. APAC Polypeptide Drug Sales Quantity by Type (2024-2034) & (MT)
Table 94. APAC Polypeptide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 95. APAC Polypeptide Drug Revenue by Type (2024-2034) & (US$ Million)
Table 96. APAC Polypeptide Drug Sales Quantity by Application (2018-2023) & (MT)
Table 97. APAC Polypeptide Drug Sales Quantity by Application (2024-2034) & (MT)
Table 98. APAC Polypeptide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 99. APAC Polypeptide Drug Revenue by Application (2024-2034) & (US$ Million)
Table 100. APAC Polypeptide Drug Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 101. APAC Polypeptide Drug Revenue by Region (2018-2023) & (US$ Million)
Table 102. APAC Polypeptide Drug Revenue by Region (2024-2034) & (US$ Million)
Table 103. APAC Polypeptide Drug Sales Quantity by Region (2018-2023) & (MT)
Table 104. APAC Polypeptide Drug Sales Quantity by Region (2024-2034) & (MT)
Table 105. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Company (2018-2023) & (MT)
Table 106. Middle East, Africa and Latin America Polypeptide Drug Revenue by Company (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Type (2018-2023) & (MT)
Table 108. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Type (2024-2034) & (MT)
Table 109. Middle East, Africa and Latin America Polypeptide Drug Revenue by Type (2018-2023) & (US$ Million)
Table 110. Middle East, Africa and Latin America Polypeptide Drug Revenue by Type (2024-2034) & (US$ Million)
Table 111. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Application (2018-2023) & (MT)
Table 112. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Application (2024-2034) & (MT)
Table 113. Middle East, Africa and Latin America Polypeptide Drug Revenue by Application (2018-2023) & (US$ Million)
Table 114. Middle East, Africa and Latin America Polypeptide Drug Revenue by Application (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Polypeptide Drug Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 116. Middle East, Africa and Latin America Polypeptide Drug Revenue by Country (2018-2023) & (US$ Million)
Table 117. Middle East, Africa and Latin America Polypeptide Drug Revenue by Country (2024-2034) & (US$ Million)
Table 118. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Country (2018-2023) & (MT)
Table 119. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity by Country (2024-2034) & (MT)
Table 120. Novartis Company Information
Table 121. Novartis Description and Overview
Table 122. Novartis Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 123. Novartis Polypeptide Drug Product and Services
Table 124. Novartis Polypeptide Drug SWOT Analysis
Table 125. Novartis Recent Developments
Table 126. Merck Serono Company Information
Table 127. Merck Serono Description and Overview
Table 128. Merck Serono Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 129. Merck Serono Polypeptide Drug Product and Services
Table 130. Merck Serono Polypeptide Drug SWOT Analysis
Table 131. Merck Serono Recent Developments
Table 132. Ferring Pharmaceuticals Company Information
Table 133. Ferring Pharmaceuticals Description and Overview
Table 134. Ferring Pharmaceuticals Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 135. Ferring Pharmaceuticals Polypeptide Drug Product and Services
Table 136. Ferring Pharmaceuticals Polypeptide Drug SWOT Analysis
Table 137. Ferring Pharmaceuticals Recent Developments
Table 138. Ipsen PHarma Biotech Company Information
Table 139. Ipsen PHarma Biotech Description and Overview
Table 140. Ipsen PHarma Biotech Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 141. Ipsen PHarma Biotech Polypeptide Drug Product and Services
Table 142. Ipsen PHarma Biotech Polypeptide Drug SWOT Analysis
Table 143. Ipsen PHarma Biotech Recent Developments
Table 144. Lilly Company Information
Table 145. Lilly Description and Overview
Table 146. Lilly Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 147. Lilly Polypeptide Drug Product and Services
Table 148. Lilly Polypeptide Drug SWOT Analysis
Table 149. Lilly Recent Developments
Table 150. Asahi Kasei Company Information
Table 151. Asahi Kasei Description and Overview
Table 152. Asahi Kasei Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 153. Asahi Kasei Polypeptide Drug Product and Services
Table 154. Asahi Kasei Polypeptide Drug SWOT Analysis
Table 155. Asahi Kasei Recent Developments
Table 156. AstraZeneca Company Information
Table 157. AstraZeneca Description and Overview
Table 158. AstraZeneca Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 159. AstraZeneca Polypeptide Drug Product and Services
Table 160. AstraZeneca Polypeptide Drug SWOT Analysis
Table 161. AstraZeneca Recent Developments
Table 162. SciClone Pharmaceuticals Company Information
Table 163. SciClone Pharmaceuticals Description and Overview
Table 164. SciClone Pharmaceuticals Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 165. SciClone Pharmaceuticals Polypeptide Drug Product and Services
Table 166. SciClone Pharmaceuticals Polypeptide Drug SWOT Analysis
Table 167. SciClone Pharmaceuticals Recent Developments
Table 168. Takeda Company Information
Table 169. Takeda Description and Overview
Table 170. Takeda Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 171. Takeda Polypeptide Drug Product and Services
Table 172. Takeda Polypeptide Drug SWOT Analysis
Table 173. Takeda Recent Developments
Table 174. Roche Company Information
Table 175. Roche Description and Overview
Table 176. Roche Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 177. Roche Polypeptide Drug Product and Services
Table 178. Roche Polypeptide Drug SWOT Analysis
Table 179. Roche Recent Developments
Table 180. Sanofi Company Information
Table 181. Sanofi Description and Overview
Table 182. Sanofi Polypeptide Drug Sales Quantity (MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2023)
Table 183. Sanofi Polypeptide Drug Product and Services
Table 184. Sanofi Recent Developments
Table 185. Key Raw Materials Lists
Table 186. Raw Materials Key Suppliers Lists
Table 187. Polypeptide Drug Distributors List
Table 188. Polypeptide Drug Customers List
Table 189. Polypeptide Drug Market Trends
Table 190. Polypeptide Drug Market Drivers
Table 191. Polypeptide Drug Market Challenges
Table 192. Polypeptide Drug Market Restraints
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Polypeptide Drug Product Picture
Figure 2. Global Polypeptide Drug Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Polypeptide Drug Market Share by Type in 2024 & 2034
Figure 4. Injection Product Picture
Figure 5. Nasal Administration Product Picture
Figure 6. Lung Administration Product Picture
Figure 7. Oral Administration Product Picture
Figure 8. Transdermal Administration Product Picture
Figure 9. Global Polypeptide Drug Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 10. Global Polypeptide Drug Market Share by Application in 2024 & 2034
Figure 11. Immunity Regulating Medicine (Allergy Infection and Immune)
Figure 12. Digestive System Drugs (Gastrointestinal Type)
Figure 13. Bone and Connective Tissue Types (Thyroid hormones Drug)
Figure 14. Gynecologic or Obstetric Drug
Figure 15. Tumor Drug
Figure 16. Urinary System Drug
Figure 17. Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Figure 18. Polypeptide Drug Report Years Considered
Figure 19. Global Polypeptide Drug Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 20. Global Polypeptide Drug Revenue 2018-2034 (US$ Million)
Figure 21. Global Polypeptide Drug Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 22. Global Polypeptide Drug Sales Quantity 2018-2034 (MT)
Figure 23. Global Polypeptide Drug Sales Quantity Market Share by Region (2018-2023)
Figure 24. Global Polypeptide Drug Sales Quantity Market Share by Region (2024-2034)
Figure 25. North America Polypeptide Drug Sales Quantity YoY (2018-2034) & (MT)
Figure 26. North America Polypeptide Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Europe Polypeptide Drug Sales Quantity YoY (2018-2034) & (MT)
Figure 28. Europe Polypeptide Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 29. China Polypeptide Drug Sales Quantity YoY (2018-2034) & (MT)
Figure 30. China Polypeptide Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 31. APAC Polypeptide Drug Sales Quantity YoY (2018-2034) & (MT)
Figure 32. APAC Polypeptide Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 33. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity YoY (2018-2034) & (MT)
Figure 34. Middle East, Africa and Latin America Polypeptide Drug Revenue YoY (2018-2034) & (US$ Million)
Figure 35. The Top 10 and Top 5 Players Market Share by Polypeptide Drug Sales Quantity in 2024
Figure 36. The Top 10 and Top 5 Players Market Share by Polypeptide Drug Revenue in 2024
Figure 37. Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 38. Global Polypeptide Drug Sales Quantity Market Share by Type (2018-2034)
Figure 39. Global Polypeptide Drug Revenue Market Share by Type (2018-2034)
Figure 40. Global Polypeptide Drug Sales Quantity Market Share by Application (2018-2034)
Figure 41. Global Polypeptide Drug Revenue Market Share by Application (2018-2034)
Figure 42. North America Polypeptide Drug Revenue Market Share by Company in 2024
Figure 43. North America Polypeptide Drug Sales Quantity Market Share by Company in 2024
Figure 44. North America Polypeptide Drug Sales Quantity Market Share by Type (2018-2034)
Figure 45. North America Polypeptide Drug Revenue Market Share by Type (2018-2034)
Figure 46. North America Polypeptide Drug Sales Quantity Market Share by Application (2018-2034)
Figure 47. North America Polypeptide Drug Revenue Market Share by Application (2018-2034)
Figure 48. North America Polypeptide Drug Revenue Share by Country (2018-2034)
Figure 49. North America Polypeptide Drug Sales Quantity Share by Country (2018-2034)
Figure 50. U.S. Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 51. Canada Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 52. Europe Polypeptide Drug Sales Quantity Market Share by Company in 2024
Figure 53. Europe Polypeptide Drug Revenue Market Share by Company in 2024
Figure 54. Europe Polypeptide Drug Sales Quantity Market Share by Type (2018-2034)
Figure 55. Europe Polypeptide Drug Revenue Market Share by Type (2018-2034)
Figure 56. Europe Polypeptide Drug Sales Quantity Market Share by Application (2018-2034)
Figure 57. Europe Polypeptide Drug Revenue Market Share by Application (2018-2034)
Figure 58. Europe Polypeptide Drug Revenue Share by Country (2018-2034)
Figure 59. Europe Polypeptide Drug Sales Quantity Share by Country (2018-2034)
Figure 60. Germany Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 61. France Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 62. U.K. Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 63. Italy Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 64. Russia Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 65. China Polypeptide Drug Sales Quantity Market Share by Company in 2024
Figure 66. China Polypeptide Drug Revenue Market Share by Company in 2024
Figure 67. China Polypeptide Drug Sales Quantity Market Share by Type (2018-2034)
Figure 68. China Polypeptide Drug Revenue Market Share by Type (2018-2034)
Figure 69. China Polypeptide Drug Sales Quantity Market Share by Application (2018-2034)
Figure 70. China Polypeptide Drug Revenue Market Share by Application (2018-2034)
Figure 71. APAC Polypeptide Drug Sales Quantity Market Share by Company in 2024
Figure 72. APAC Polypeptide Drug Revenue Market Share by Company in 2024
Figure 73. APAC Polypeptide Drug Sales Quantity Market Share by Type (2018-2034)
Figure 74. APAC Polypeptide Drug Revenue Market Share by Type (2018-2034)
Figure 75. APAC Polypeptide Drug Sales Quantity Market Share by Application (2018-2034)
Figure 76. APAC Polypeptide Drug Revenue Market Share by Application (2018-2034)
Figure 77. APAC Polypeptide Drug Revenue Share by Region (2018-2034)
Figure 78. APAC Polypeptide Drug Sales Quantity Share by Region (2018-2034)
Figure 79. Japan Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 80. South Korea Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 81. China Taiwan Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 82. Southeast Asia Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 83. India Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 84. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity Market Share by Company in 2024
Figure 85. Middle East, Africa and Latin America Polypeptide Drug Revenue Market Share by Company in 2024
Figure 86. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity Market Share by Type (2018-2034)
Figure 87. Middle East, Africa and Latin America Polypeptide Drug Revenue Market Share by Type (2018-2034)
Figure 88. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity Market Share by Application (2018-2034)
Figure 89. Middle East, Africa and Latin America Polypeptide Drug Revenue Market Share by Application (2018-2034)
Figure 90. Middle East, Africa and Latin America Polypeptide Drug Sales Quantity Share by Country (2018-2034)
Figure 91. Middle East, Africa and Latin America Polypeptide Drug Revenue Share by Country (2018-2034)
Figure 92. Brazil Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 93. Mexico Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 94. Turkey Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 95. Israel Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 96. GCC Countries Polypeptide Drug Revenue (2018-2034) & (US$ Million)
Figure 97. Polypeptide Drug Value Chain
Figure 98. Polypeptide Drug Production Process
Figure 99. Channels of Distribution (Direct Vs Distribution)
Figure 100. Distributors Profiles
Figure 101. Bottom-up and Top-down Approaches for This Report
Figure 102. Data Triangulation
Figure 103. Key Executives Interviewed